Kostoula Arvaniti
Overview
Explore the profile of Kostoula Arvaniti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
451
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arvaniti K, Lathyris D, Koulenti D
Intensive Crit Care Nurs
. 2025 Jan;
87:103942.
PMID: 39826339
No abstract available.
2.
Rapti V, Poulakou G, Mousouli A, Kakasis A, Pagoni S, Pechlivanidou E, et al.
Antibiotics (Basel)
. 2024 Sep;
13(9).
PMID: 39334987
Antimicrobial resistance poses a major threat to human health worldwide and the implementation of antimicrobial stewardship programs (ASPs), including antimicrobial de-escalation (ADE), is a multifaceted tool for minimizing unnecessary or...
3.
Paiva J, Rello J, Eckmann C, Antonelli M, Arvaniti K, Koulenti D, et al.
Eur J Intern Med
. 2024 Jul;
129():100-110.
PMID: 39079800
We compared epidemiology of intra-abdominal infection (IAI) between immunocompromised and non-immunocompromised ICU patients and identified risk factors for mortality. We performed a secondary analysis on the "AbSeS" database, a prospective,...
4.
Poulopoulou A, Sidiropoulou A, Sarmourli T, Zachrou E, Michailidou C, Zarras C, et al.
Med Mycol
. 2024 Jun;
62(7).
PMID: 38877671
Candida auris is an emerging fungal pathogen associated with multi-drug resistance rates and widespread outbreaks in hospitals and healthcare units worldwide. Sequencing studies have revealed that different clonal lineages of...
5.
De Bus L, Arvaniti K, Sjovall F
Intensive Care Med
. 2024 May;
50(8):1338-1341.
PMID: 38739275
No abstract available.
6.
Wozniak H, Tabah A, Barbier F, Ruckly S, Loiodice A, Akova M, et al.
Ann Intensive Care
. 2024 May;
14(1):70.
PMID: 38698291
Background: Hospital-acquired bloodstream infections are common in the intensive care unit (ICU) and have a high mortality rate. Patients with cirrhosis are especially susceptible to infections, yet there is a...
7.
Buetti N, Tabah A, Setti N, Ruckly S, Barbier F, Akova M, et al.
Intensive Care Med
. 2024 Apr;
50(6):1017-1018.
PMID: 38587556
No abstract available.
8.
Buetti N, Tabah A, Setti N, Ruckly S, Barbier F, Akova M, et al.
Intensive Care Med
. 2024 Mar;
50(6):873-889.
PMID: 38498170
Purpose: The primary objective of this study was to evaluate the associations between centre/country-based factors and two important process and outcome indicators in patients with hospital-acquired bloodstream infections (HABSI). Methods:...
9.
Dejonckheere M, Antonelli M, Arvaniti K, Blot K, CreaghBrown B, de Lange D, et al.
J Intensive Med
. 2024 Jan;
4(1):81-93.
PMID: 38263964
Background: The -classification defines specific phenotypes of patients with intra-abdominal infection based on the (1) setting of infection onset (community-acquired, early onset, or late-onset hospital-acquired), (2) presence or absence of...
10.
De Waele J, Coccolini F, Lagunes L, Maseda E, Rausei S, Rubio-Perez I, et al.
Antibiotics (Basel)
. 2023 Dec;
12(12).
PMID: 38136745
This comprehensive review aims to provide a practical guide for intensivists, focusing on enhancing patient care associated with nosocomial peritonitis (NP). It explores the epidemiology, diagnosis, and management of NP,...